Millennium Management’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
Other funds holding TTNP
TRCT
MA
GWSA
NRG
Millennium Management's TTNP Position: Q1 2024 in Review
Millennium Management sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 756 shares — an estimated $6.23K sold.
Millennium Management first reported a position in TTNP in Q4 2015 and held it in 13 quarters. The position peaked at $437K in Q2 2017. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.
- Millennium Management reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Millennium Management sold 756 Titan Pharmaceuticals shares in Q1 2024, an estimated $6.23K.
- Millennium Management first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 13 quarters.
- Millennium Management's Titan Pharmaceuticals position peaked at $437K in Q2 2017.
- 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.